Answers are grounded in this paper and cite their sources.
Proteomics study identifies S100P predicting early recurrence and survival in distal cholangiocarcinoma, suggesting clinical utility for risk stratification.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: